Aurinia Pharmaceuticals AUPH Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $34.36M+47.2% | $210.79M+14,651% | $31.55M+120% | $21.51M+2,880% | $23.34M+317% | ||
| $4.82M-0.8% | $4.86M0.0% | $4.87M-0.6% | $4.86M+0.4% | $4.86M+0.2% | ||
| -$866K+74.6% | $6.73M-24.8% | $5.92M-28.9% | $5.44M-36.6% | -$3.41M-159% | ||
| $32.56M+2,405% | $45.67M+51.7% | $44.45M+161% | $44.24M+179% | $1.3M+107% | ||
| -$18.08M-158% | -$36.76M-194% | —— | —— | $31.03M-37.0% | ||
| $36.17M-22.9% | $0-100% | $8.67M— | $42.56M+594% | $46.92M+281% | ||
| -$53.69M-8.8% | -$1.89M+91.8% | -$10.49M-285% | -$44.39M-437% | -$49.34M-228% | ||
| -$39.21M-131% | —— | —— | -$13.43M+56.8% | -$17.01M-209% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aurinia Pharmaceuticals generate?
- Aurinia Pharmaceuticals (AUPH) generated $166.9M in operating cash flow over the trailing twelve months.
- Where does Aurinia Pharmaceuticals's cash flow data come from?
- Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
